High performance liquid chromatography (HPLC) is
the reference method for cyclosporin (CyA) measurements
but therapeutic monitoring of the drug is frequently
made using the more practical immunoassays.
Cross-reactivity with CyA metabolites may
compromise the specificity of immunoassays, particularly
in liver graft recipients where metabolites may
accumulate. The aim of this study was to compare
with HPLC the performance of two recently introduced
CyA immunoassays (the AxSYM fluorescent polarisation
immunoassay (FPIA) and non-extraction CEDIA
assay). The comparison was extended to the well-established
TDx monoclonal FPIA (TDx mono) and the
enzyme multiplied (EMIT)-specific assays and to the
polyclonal FPIA (TDx poly), in which metabolite cross-reactivity
is extensive. Assays were performed on 106
blood samples (taken 6 days to 118 months post-liver
transplant) and results were compared by non-parametric
regression analysis and difference plots.
AxSYM and CEDIA showed both constant and proportional
bias against HPLC (unlike EMIT) but the mean
difference from HPLC was least for AxSYM (2.7 ?g/l
Print ISSN: 1434-6621
Volume: 38, 11/2000
Pages: 1205 - 1207